Zobrazeno 1 - 10
of 10
pro vyhledávání: '"W. G. in 't Hout"'
Autor:
A F, Roffel, K, Ensing, C R, Elzinga, W G, in 't Hout, E J, van Tintelen, R A, de Zeeuw, J, Zaagsma
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 314
The heterogeneous binding behavior exhibited by classical quaternary muscarinic antagonists was further investigated in order to establish possible molecular and/or environmental differences between the high (Q1) and low (Q2) affinity binding sites.
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 314
In competition experiments with the tertiary radioligand [3H]dexetimide, classical quaternary muscarinic antagonists like ipratropium bromide and N-methylscopolamine bromide distinguished two muscarinic binding sites in bovine brain (total brain minu
Publikováno v:
Journal of biochemical and biophysical methods, 13(2), 85-96
In quantitative radioreceptor assays the amount of a drug present in the medium to be assayed is inversely related to the amount of receptor-bound radiolabelled ligand. Usually, separation of the bound and free fractions of radiolabelled ligand is do
Publikováno v:
Journal of receptor research, 8(6), 871-883
In radioligand binding studies, the accuracy of the specific activity of the radiolabeled ligand has a large impact on the calculated receptor concentration and on the calculated affinities of both labeled and competitive ligands. A radioreceptor ass
Autor:
H. M. Pinedo, Rokus A. de Zeeuw, E. A. Hogendoorn, R. van Gijn, S. V. Rose, M. Barnard, H. H. van den Broek, O. A. G. J. van der Houwen, H. M. Ruijten, P. De Moerloose, M. A. J. van Opstal, A. J. Baars, A. Bult, L. G. D. Lammerts van Bueren, K. Ensing, E. v.d. Heeft, J. H. G. Jonkman, W. P. van Bennekom, L. P. C. P. Delbressine, R. W. Frei, H. J. van Rossum, W. G. in 't Hout, C. van de Water, J. J. M. de Clippeleir, Ben F. H. Drenth, K. Sierat, U. A. Th. Brinkman, N. Haagsma, G. de Groot, Naeem Hasan Khan, E. H. Groot Bramel, D. J. K. van der Stel, C. P. Groen, W. J. M. Underberg, P. S. L. Janssen, D. E. M. M. Vendrig, J. A. De Schutter, P. A. Maessen, M. J. M. v. Zeeland, A. Mekking, P. J. M. Kwakman, J. H. N. van den Berg, A. L. L. Duchateau, J. K. van den Bergh-Swart, H. Vanderhaeghe, P. A. T. A. Melgers, M. W. Lobbezoo, C. E. Goewie, H. de Bree, N. G. F. M. Lammers, H. M. Steinbuch, P. W. Zoontjes, R.A. de Zeeuw, B. C. Goverde, J. Hempenius, A. S. Horn, D. A. Bloemhof, E. Roets, O. A. M. Brockhoff, R. L. A. E. Hanmelinck, M. Otagiri, P. M. J. Coenegracht, D. A. Doornbos, F. J. Spruit, T. K. Gerding, Th. Cachet, O. E. de Noord, Karla G. Feitsma, S. C. M. Lubbers, H. van Blitterswijk, O. R. Leeuwenkamp, R. W. Stephany, M. P. van Berkel, S. L. Verweij, G. J. de Jong, B. F. H. Drenth, W. J. F. van der Vijgh, P. Krabbenborg, J.M. van den Berg, H. van Beek, O. Beckers, A. C. A. Paalman, F. M. Kaspersen, W. J. F. vd Vijh, N. Lammers, L. A. van Ginkel, J. Hoogmartens, P. J. H. Hendricks, K. B. Mross, T. A. Verstappen, J. Teeuwsen, J. J. M. Holthuis, J. Tipker, G. W. M. v. Aalst, P. R. Kootstra, J. W. v. Nispen, Jos H. Beijnen, F. Elferink, B. C. A. Tepas, A. Blokland, A. J. P. M. de Jong
Publikováno v:
Pharmaceutisch Weekblad. 10:30-50
A number of different processes clear peptides from the circulation. These will be described and illustrated using examples from a range of peptide hormones and analogues.
Publikováno v:
European Journal of Clinical Pharmacology, 37(5), 507-512. Springer Verlag
Oxitropium bromide (OXBR) is a new anticholinergic drug, which is expected to be useful in the treatment of nocturnal asthma. The only pharmacokinetic data were obtained with the 14C-labelled compound. A sensitive radioreceptor assay for the determin
Autor:
M. Barnard, J. H. Beijnen, S. C. M. Lubbers, O. A. G. J. van der Houwen, M. W. Lobbezoo, W. J. M. Underberg, Th. Cachet, E. Roets, J. Hoogmartens, H. Vanderhaeghe, H. de Bree, D. J. K. van der Stel, O. A. M. Brockhoff, M. P. van Berkel, K. Sierat, G. de Groot, B. C. A. Tepas, O. E. de Noord, J. Hempenius, P. M. J. Coenegracht, J. H. G. Jonkman, D. A. Doornbos, J. A. De Schutter, P. De Moerloose, L. P. C. P. Delbressine, F. M. Kaspersen, A. Blokland, A. L. L. Duchateau, T. A. Verstappen, P. J. H. Hendricks, F. Elferink, O. R. Leeuwenkamp, H. M. Pinedo, W. J. F. vd Vijh, K. Ensing, D. A. Bloemhof, W. G. in 't Hout, R. A. de Zeeuw, Karla G. Feitsma, Ben F. H. Drenth, Rokus A. de Zeeuw, T. K. Gerding, B. F. H. Drenth, A. S. Horn, C. P. Groen, J. Tipker, J. K. van den Bergh-Swart, F. J. Spruit, J. H. N. van den Berg, E. H. Groot Bramel, O. Beckers, M. Otagiri, P. S. L. Janssen, J. W. v. Nispen, P. A. T. A. Melgers, M. J. M. v. Zeeland, R. L. A. E. Hanmelinck, B. C. Goverde, G. W. M. v. Aalst, P. R. Kootstra, H. H. van den Broek, E. A. Hogendoorn, C. E. Goewie, P. J. M. Kwakman, U. A. Th. Brinkman, R. W. Frei, G. J. de Jong, N. G. F. M. Lammers, J. H. M. van den Berg, N. Lammers, H. M. Ruijten, P. A. Maessen, K. B. Mross, W. J. F. van der Vijgh, Naeem Hasan Khan, S. V. Rose, L. G. D. Lammerts van Bueren, H. van Beek, A. J. Baars, L. A. van Ginkel, H. M. Steinbuch, H. J. van Rossum, H. van Blitterswijk, P. W. Zoontjes, E. v.d. Heeft, A. J. P. M. de Jong, R. W. Stephany, R. van Gijn, J. J. M. de Clippeleir, S. L. Verweij, A. C. A. Paalman, M. A. J. van Opstal, P. Krabbenborg, J. J. M. Holthuis, W. P. van Bennekom, A. Bult, C. van de Water, N. Haagsma, D. E. M. M. Vendrig, A. Mekking, J. Teeuwsen
Publikováno v:
Pharmaceutisch Weekblad. 10:58-67
Publikováno v:
Analytical letters, 20(3), 489-502
Radioreceptor assays (RRA) have been employed for the quantitation of several tertiary and quaternary anticholinergic drugs in plasma and urine. In order to improve the sensitivity and precision of the method, the receptor preparation was standardize
Publikováno v:
Arzneimittel-Forschung. 38(1)
6 beta,7 beta-Epoxy-3a(1aH,5aH)-tropanyl-(S)-tropate (scopolamine) has proved to be a very effective drug in the prevention of motion sickness, however, the drug has a small therapeutic window, a low bioavailability and a short half-life. A transderm
Publikováno v:
Pharmaceutical research. 5(5)
N-0437 is a recently developed dopamine (D2) agonist, theoretically attractive in the therapy of Parkinson's disease and glaucoma. Since its high potency allows small doses of the compound in clinical use and as extensive metabolism occurs in animals